SPIA
BBNX

Steward Partners Investment Advisory’s Beta Bionics BBNX Stock Holding History

Steward Partners Investment Advisory’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.1K Buy
3,003
+979
+48% +$14.5K ﹤0.01% 3041
2025
Q4 		$61.7K Buy
2,024
+509
+34% +$13.6K ﹤0.01% 2561
2025
Q3 		$30.1K Hold
1,515
– – ﹤0.01% 2891
2025
Q2 		$22.1K Buy
1,515
+400
+36% +$5.66K ﹤0.01% 2879
2025
Q1 		$13.6K Buy
+1,115
New +$20.8K ﹤0.01% 2961

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Steward Partners Investment Advisory's BBNX Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Beta Bionics (BBNX) stake by 48% in Q1 2026, buying an estimated $14.5K and bringing the position to 3,003 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3041.

Steward Partners Investment Advisory first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $61.7K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Steward Partners Investment Advisory held 3,003 shares of Beta Bionics worth $30.1K as of Q1 2026.
  • Steward Partners Investment Advisory bought 979 Beta Bionics shares in Q1 2026, an estimated $14.5K.
  • Beta Bionics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3041 holding.
  • Steward Partners Investment Advisory first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Steward Partners Investment Advisory's Beta Bionics position peaked at $61.7K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.